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Tomatidine enhances lifespan and 
healthspan in C. elegans through 
mitophagy induction via the SKN-1/
Nrf2 pathway
Evandro F. Fang1,*, Tyler B. Waltz1,*, Henok Kassahun1,2, Qiping Lu1, Jesse S. Kerr1, 
Marya Morevati1,3, Elayne M. Fivenson1, Bradley N. Wollman1, Krisztina Marosi4, 
Mark A. Wilson4, Wendy B. Iser4, D. Mark Eckley5, Yongqing Zhang5, Elin Lehrmann5, 
Ilya G. Goldberg5, Morten Scheibye-Knudsen1,3, Mark P. Mattson4, Hilde Nilsen2, 
Vilhelm A. Bohr1,3,# & Kevin G. Becker5,#
Aging is a major international concern that brings formidable socioeconomic and healthcare challenges. 
Small molecules capable of improving the health of older individuals are being explored. Small 
molecules that enhance cellular stress resistance are a promising avenue to alleviate declines seen 
in human aging. Tomatidine, a natural compound abundant in unripe tomatoes, inhibits age-related 
skeletal muscle atrophy in mice. Here we show that tomatidine extends lifespan and healthspan in 
C. elegans, an animal model of aging which shares many major longevity pathways with mammals. 
Tomatidine improves many C. elegans behaviors related to healthspan and muscle health, including 
increased pharyngeal pumping, swimming movement, and reduced percentage of severely damaged 
muscle cells. Microarray, imaging, and behavioral analyses reveal that tomatidine maintains 
mitochondrial homeostasis by modulating mitochondrial biogenesis and PINK-1/DCT-1-dependent 
mitophagy. Mechanistically, tomatidine induces mitochondrial hormesis by mildly inducing ROS 
production, which in turn activates the SKN-1/Nrf2 pathway and possibly other cellular antioxidant 
response pathways, followed by increased mitophagy. This mechanism occurs in C. elegans, primary rat 
neurons, and human cells. Our data suggest that tomatidine may delay some physiological aspects of 
aging, and points to new approaches for pharmacological interventions for diseases of aging.
Aging is becoming an international challenge to healthcare systems in both developed and developing countries. 
Unveiling the most common underlying causes of aging will permit the development of safe interventional strat-
egies to delay aging and extend healthspan in humans1,2. Several cellular alternations that may be critical towards 
the development of an aging phenotype been identified, including mitochondrial dysfunction, oxidative stress, 
genomic instability, and loss of proteostasis3. Research regarding mitochondrial dysfunction and age-related dis-
eases, such as neurodegenerative diseases, have highlighted the importance of mitochondrial homeostasis for 
healthy aging and disease resistance4–6. Mitochondrial homeostasis relies on mitochondrial biogenesis, regulated 
in part by AMPK and PGC-1a, and by selective removal of dysfunctional or damaged mitochondria by mitochon-
drial autophagy (mitophagy). Impaired mitophagy may occur in physiological aging, premature aging diseases, 
neurodegenerative diseases, and sarcopenia6–9.
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While the average lifespan has increased markedly over the past two centuries, the number of people liv-
ing with one or more chronic age-related diseases has also increased, particularly in sedentary and over nour-
ished individuals10,11. Prominent age-related diseases are diabetes, cardiovascular disease, cancers, arthritis, and 
Alzheimer’s and Parkinson’s diseases. Studies on a broad array of organisms, including C. elegans, flies, mice and 
humans, have shown that dietary energy restriction and exercise can counteract age-related functional decline 
of cells and organs, and can prevent or delay the onset of various age-related diseases12–15. Emerging evidence 
suggests that energy restriction, fasting, and exercise may increase cellular and organismal resistance to aging 
and disease by activating multiple signaling pathways that protect against oxidative, metabolic, and proteotoxic 
stress16,17. Examples of these signaling pathways include up-regulation of antioxidant enzymes, sirtuins, DNA 
repair efficiency, trophic factor production, general autophagy, and mitophagy9,16,18–20. These stress-related activ-
ities are examples of hormesis, in which moderate levels of biological stress, such as exercise, elicit a biological 
response that confers resistance to greater amounts of stress17,21. Interestingly, recent findings suggest that, in 
addition to energy restriction and exercise, certain ‘noxious’ chemicals in fruits, vegetables and other plants may 
counteract aging and disease by inducing adaptive (hormetic) stress responses in cells22,23.
It has been suggested that small compound inhibition of growth hormone/IGF-1 axis, mTOR-S6K pathway, 
or activation of AMPK, specific sirtuins, or NF-E2 related factor 2 (Nrf2), may improve healthspan in humans2,24. 
Interestingly, many of these pathways are directly or indirectly linked to mitochondria biogenesis (sirtuins, 
AMPK) and mitophagy (mTOR, SIRT1)2,4,19,25,26. The discovery of phytochemicals that affect these aging-related 
pathways may extend our understanding of aging mechanisms and point to novel therapeutic interventions that 
promote healthy aging and counteract disease processes23. Tomatoes are a common, nutritious and inexpensive 
vegetable containing many bioactive compounds27. Tomatidine is the aglycone of α -tomatine, a major glycoalka-
loid found in unripe tomato fruits, leaves and stems27. Green tomatoes have a high content of tomatine of up to 
500 mg/kg, while ripe red tomatoes have less than 5 mg/kg27. Tomatidine, a metabolite of tomatine, has multi-
ple beneficial biological effects including anti-inflammatory28, anti- tumorigenic, and lipid-lowering activities29. 
Recently, tomatidine was shown to increase mitochondrial DNA content, muscle fitness, as well as lower adipos-
ity in a mouse model of skeletal muscle atrophy, suggesting a role in improving muscle healthspan30. However, 
molecular mechanisms underlying this activity of tomatidine is largely unexplored, and broad health benefits, like 
lifespan, have not been investigated.
Here, we show that tomatidine treatment in C. elegans extends lifespan, improves mitochondrial function, and 
protects muscle function against age-associated deterioration. We found that tomatidine maintains mitochon-
drial homeostasis by modulating mitochondrial biogenesis and PINK-1/DCT-1-dependent mitophagy in cells of 
multiple species, including nematodes, rats, and humans. Tomatidine induces mild oxidative stress, activates the 
SKN-1/Nrf2 pathway and other cellular antioxidant responses, which induces mitophagy.
Results
Tomatidine extends lifespan of wild-type C. elegans. Lifespan of the nematode C. elegans quantifies 
organismal longevity that depends upon various aging processes31. We exposed N2 (wild type) C. elegans to 
tomatidine at concentrations of 0, 25, and 50 μ M beginning at the L4 stage, and C. elegans survival was recorded. 
Tomatidine consistently extended lifespan at a concentration of 25 μ M with (7.0 ± 0.8)% increase (Figs 1A and 
S1B), while there was no significant change of lifespan at 50 μ M (Figure S1A). When assessing the survival curve 
further, it was noted that many C. elegans exposed to 50 μ M tomatidine died at relatively early ages (7 to 13 
days) compared to C. elegans not exposed to tomatidine, but those that survived this period of increased death 
had a longer maximal lifespan (Figure S1A). This biphasic dose – response effect of tomatidine is consistent 
with a hormesis-based mechanism of action17. We also noticed that 50 μ M tomatidine exhibited some toxicity to 
C. elegans healthspan as well (data not shown), while no detectable toxicity was noticed with tomatidine concen-
trations of 25 μ M or less. Based on these dose-dependent responses in lifespan, 25 μ M tomatidine was selected as 
an optimal concentration for most subsequent experiments.
Tomatidine enhances muscle function and modulates metabolism in C. elegans. There is a dra-
matic physical decline in swimming ability, pharyngeal pumping, and maximum movement velocity as C. elegans 
age32,33. These behaviors reflect the overall muscle health of C. elegans, and any attenuation of these age-related 
declines due to an intervention would suggest anti-aging effect on muscle cells. Our data consistently showed 
age-dependent decreases of pharyngeal pumping and swimming movement in N2 C. elegans (Fig. 1B,C). C. elegans 
treated with 25 μ M tomatidine exhibited enhanced pharyngeal pumping at multiple time points during their 
life (Fig. 1B). Although 25 μ M tomatidine did not affect swimming ability in young (adult day 4) C. elegans, 
as they aged (adult day 12), tomatidine significantly delayed the age-related decrease of swimming movement 
scores (48% improvement compared with vehicle) (Fig. 1C). Maximum movement velocity in C. elegans has 
been suggested to decline with age and to correlate with longevity33. We verified the decrease of maximum move-
ment velocity with age in N2 C. elegans, but found no significant differences in maximum movement velocity in 
tomatidine-treated C. elegans from adult days 4 to 10 compared with vehicle treatment (Figure S1C, and data not 
shown). Collectively, tomatidine is able to alleviate some features of aging-related physical decline in C. elegans, 
which indicates an improvement in healthspan.
We further asked whether the improvement of swimming and pharyngeal pumping implied inhibition of sar-
copenia, so we performed phalloidin staining on worm muscle cells to assess actin filament structure34. We care-
fully analyzed the muscle morphology in day 4 and day 8 adult worms treated with or without tomatidine, and 
presented the data as percentage of muscle cells that possessed “no damage”, “minor damage”, or “major damage” 
(Figure S1E). Tomatidine had no significant effect on actin filament damage in adult day 4 worms. However, in day 
8 worms, tomatidine decreased the percentage of muscle cells that exhibited severe damage: first repeat, 54% in N2 
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Figure 1. Tomatidine extends lifespan and healthspan in C. elegans. (A) Lifespans of tomatidine treated 
C. elegans were assessed (n = 91 for vehicle and n = 126 for Tomatine group). (B,C) Healthspan metrics of 
pharyngeal pumping (B) and swimming movement (C) for C. elegans treated with 25 μ M tomatidine  
(n = 10–20). (D,E) Morphology of C. elegans pharynx was assessed using machine learning technique to 
determine age state of pharynx (D, n = 30 worms in three separate experiments), with a representative set 
of pictures shown (E). (F) Metabolomics showing the relative change in C. elegans metabolome with or 
without tomatidine. Adult D7 worms from tomatidine or vehicle-treated groups were collected and subjected 
to ALEX-CIS GCTOF mass spectrometry with more than 150 metabolites identified. See Table S1 for a 
complete list. All bar graphs are expressed as mean ± S.E.M., *p < 0.05; **p < 0.01; ***p < 0.001. See also 
Figures S1 and S2.
www.nature.com/scientificreports/
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(veh) compared with 24% N2 (tomatidine); second repeat 15% in N2 (veh) vs. 7% N2 (tomatidine) (Figure S1F). 
Collectively, these data suggest that tomatidine inhibits sarcopenia not only in mice30 but also in C. elegans.
We further investigated whether tomatidine-induced improvement of muscle-dependent behaviors could 
be related to the preservation of muscle cells. We previously showed that pharynx muscle morphology reflects 
the aging state of the whole organism, and based on this mechanism in combination with machine-learning 
software, we analyzed the effects of tomatidine on age stage scoring of pharynx in accordance to the previous 
publications35,36. We defined C. elegans pharynx scoring from stage 0 (young) to stage 3 (old): stage 0 C. elegans 
are predominantly found in the first 2 days of adulthood and are developing fecundity. Both Stage-1 and Stage-2 
C. elegans are actively laying eggs. Stage-3 C. elegans are predominantly found after egg laying has ceased, begin-
ning as early as day 7 of adulthood. Administration of 10 μ M or 25 μ M tomatidine consistently lowered the 
age-states of individual C. elegans pharynx (Figs 1D,E and S1D). Notably, for 25 μ M tomatidine-treated worms, 
there are more stage 2 pharynx compared to the Day 7 vehicle condition, but there are no stage 3 pharynx in this 
group while stage 3 pharynx is 5% in Day 7 vehicle condition. All these data suggest that tomatidine may attenu-
ate age-related pharynx deterioration. These results suggest that tomatidine likely enhances pharyngeal pumping 
by preservation of youthful pharynx morphology.
Efficient metabolism is important for health, and decrements in cell metabolism have been implicated in 
age-related diseases and longevity37,38. To test the effect of tomatidine on C. elegans metabolomes, adult D7 toma-
tidine or vehicle-treated whole body tissues of C. elegans were collected and subjected to ALEX-CIS GCTOF mass 
spectrometry with more than 150 metabolites identified (Fig. 1F and Table S1). Tomatidine affected the levels of 
several metabolites, and we chose to focus on metabolites relating to the TCA cycle and amino acid metabolism, 
due to their importance in energy production and maintenance of muscle mass, and therefore muscle perfor-
mance. A reduction of many TCA intermediates, including citrate, isocitrate, and malate, coupled with decreased 
lactate production and steady glycolysis intermediates suggests that tomatidine enhances general levels of oxida-
tive phosphorylation in C. elegans. Tomatidine-treated C. elegans exhibited increased levels of many free amino 
acids (leucine, threonine, isoleucine, tryptophan, proline, arginine, histidine, valine, methionine) suggesting an 
increased catabolism (Figure S2A). Collectively, these results demonstrate that tomatidine affects several meta-
bolic pathways which may be integral to its anti-aging properties.
Gene expression analysis reveals regulation of mitochondrial pathway by tomatidine. We next 
investigated the mechanism(s) by which tomatidine enhances lifespan and muscle-related healthspan. To this 
end, we performed whole-genome gene expression analysis using microarrays to elucidate potential pathways that 
might mediate the anti-aging action of tomatidine. Heatmap analysis suggested that tomatidine had significant 
effects on the profiles of expressed transcripts (Fig. 2A). Gene ontology (GO) analysis identified 36 GO signalling 
pathways upregulated and 25 GO signalling pathways downregulated (Fig. 2B and Table S2). Intriguingly, toma-
tidine had significant effects on mitochondria function, as evidenced by changes in several mitochondria-related 
signaling pathways, including those affecting the electron transport chain, the mitochondrial inner membrane 
space and matrix, and the metabolism of glutathione (Fig. 2B). Additionally, the GO analysis also suggests the 
improvement of other health-related signaling pathways, including pathways associated with cell fate regulation, 
Figure 2. Effects of tomatidine on the transcriptome of C. elegans. (A) Heatmap of microarray data showing 
genes that were differentially expressed in control and tomatidine-treated nematodes. (B) A list of significantly 
changed GO signaling pathways in tomatidine-treated worms compared with vehicle-treated changes. 
Mitochondria-related pathways are marked orange. See Table S2 for a complete gene list.
www.nature.com/scientificreports/
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metabolism, ROS regulation, and increased resistance to exogenous stress (response to gamma radiation). These 
data suggest that tomatidine affects mitochondrial function and ROS metabolism.
Evidence that tomatidine stimulates mitochondrial biogenesis and mitophagy. Given the sig-
nificant changes of tomatidine on mitochondria-related signaling pathways, we examined how tomatidine modu-
lates mitochondrial homeostasis in C. elegans, primary rat cortical neurons, and human cells. Since mitochondrial 
homeostasis is tightly regulated by mitochondrial biogenesis and quality control through mitophagy5,39, we first 
determined whether tomatidine changes mitochondrial content and morphology in C. elegans. The pharynx is an 
important organ composed of pharyngeal muscles that show age-dependent loss of function (pumping, Fig. 1B) 
and structure (Fig. 1E), which are attenuated by tomatidine. We therefore examined mitochondrial distribution 
in the pharynx using MitoTracker Red. There were more mitochondria in pharyngeal cells in tomatidine-treated 
C. elegans compared with vehicle control (Fig. 3A). We further verified tomatidine-induced mitochondrial bio-
genesis using a muscle specific pmyo-3::gfp strain (ccIs4251) (Fig. 3B). Since there is an age-dependent disorgan-
ization of mitochondrial network5, we took advantage of this myo-3 strain and used a semi-quantitative rating 
scale to evaluate the mitochondrial networks in a double-blind manner; the lowest value of one indicates highly 
impaired mitochondrial network, while a value of five signifies optimally organized mitochondrial network run-
ning in parallel with the myofilament lattice (see Methods). Tomatidine moderately increased the mitochon-
drial network morphology score (control, 3.4; tomatidine, 3.9) (Fig. 3B,C). Tomatidine-induced mitochondrial 
biogenesis was conserved from C. elegans to mammalian cells since treatment of primary rat cortical neurons 
with 4 μ M tomatidine increased their mitochondrial content, mitochondrial membrane potential, and cellular 
ROS (Figure S2B–D). Tomatidine increased, in a concentration-dependent manner, the expression of several 
major mitochondrial proteins in a human neural cell line including the inner mitochondrial membrane pro-
tein COX-VI, HSP-60 (a mitochondrial protein chaperone), superoxide dismutase 2 (SOD2), and mitochondrial 
Complex IV-COX II (Fig. 3D). These data show that tomatidine affects mitochondrial content and quality.
In view of the intricate interplay between mitochondrial biogenesis and mitophagy5,39, we asked if tomati-
dine affects mitophagy. A series of novel techniques were applied to critically investigate mitophagy. A mito-
phagy reporter strain in C. elegans has been established recently whereby colocalization of LGG-1 (the C. elegans 
homolog of a key mammalian autophagy marker LC3) and mitochondrial outer membrane localized mitophagy 
receptor DCT-1 (a putative orthologue to the mammalian NIX/BNIP3L) would indicate mitochondria under-
going mitophagy5. C. elegans were treated with 25 μ M tomatidine from the L4 stage, followed by imaging at 
adult day 4. The data showed that 25 μ M tomatidine induced an increase of mitophagy in C. elegans muscle cells 
(Fig. 3E and quantification in S2E). We further asked whether tomatidine can also induce mitophagy in primary 
rat cerebral cortical neurons and human neural cells. A commercial kit was applied for mitophagy detection 
in which a pH-dependent increase of fluorescence detects incidence of “mitolysosomes” (which occur when 
mitochondria in autophagosomes fuse with acidic lysosomes) which can be detected as the colocalization of the 
‘Mtphagy’ dye and a lysosome dye (see Methods for details). In line with an induction of mitophagy in C. elegans, 
tomatidine increased mitophagy incidence in rat cortical neurons as indicted by increased colocalization of 
‘Mtphagy’ dye with the lysosome dye (Fig. 3F,G). Similarly, tomatidine also induced mitophagy in human neural 
cells (Fig. 3H,I). Additionally, we used a standard mt-mKeima mitophagy reporter to verify changes of mitophagy 
by tomatidine; the mt-mKeima exhibits green fluorescence (excitation 488 nm) in healthy mitochondria (pH ~8) 
and a red signal (excitation 561 nm) when mitochondria are in mitolysosomes40,41. As expected, tomatidine 
increased the mt-mKeima signal (561 nm) indicating higher mitophagy (Fig. 3J–K). In conclusion, tomatidine 
can induce mitophagy across species.
We further explored how tomatidine-induced increases in healthy mitochondria might affect overall mito-
chondrial respiratory chain function in the entire C. elegans by examining basal oxygen consumption rate (OCR) 
with Seahorse XF extracellular flux instrument. C. elegans were exposed to increasing doses of tomatidine from 
the L4 stage, and basal OCR was measured at adult days 1 and 4. There was a trend towards an age-dependent 
decrease of OCR between adult day 1 and 4C. elegans, and tomatidine increased basal OCR in adult day 4 worms 
compared age-matched vehicle-treated control C. elegans (Fig. 3L), suggesting increased mitochondrial quality. 
Taken together, these results suggest that tomatidine improves mitochondrial homeostasis through induction 
of mitochondrial biogenesis and mitophagy, and that this process is conserved across species from C. elegans to 
human cells.
Tomatidine-induced healthspan improvement requires PINK-1/DCT-1-related mitophagy. 
Mitophagy plays a primary role in mitochondrial quality control, and impaired mitophagy causes neurodegen-
eration, dysfunctional cell metabolism, and even premature aging and shorter lifespan in laboratory animal 
models4,5,8,9,42. In C. elegans, the proteins PINK-1 and DCT-1 are two critical conserved executors of mito-
phagy, and may act on a similar genetic pathway to induce mitophagy5. To investigate the roles of mitophagy 
in tomatidine-related health benefits in wild type C. elegans, we knocked down dct-1 using RNA interference 
(RNAi) and examined changes in pharyngeal pumping (Fig. 4A). In older C. elegans (day 9), dct-1 knockdown 
exacerbated the age-dependent decrease of pharyngeal pumping. Importantly, dct-1 knockdown abolished 
tomatidine-induced increase of pumping measured in 5 and 9 day-old adults, unveiling an essential role of mito-
phagy induction in tomatidine-induced increase of pumping (Fig. 4A).
To further investigate the roles of mitophagy in tomatidine-induced health benefits, we assessed 
mitophagy-depleted worms for stress resistance. N2 C. elegans were sensitive to mitochondrial complex I inhibitor 
rotenone-induced death with 21% survival. Tomatidine treatment doubled the survival of rotenone-treated worms 
to over 40% (Fig. 4B). The protective effect of tomatidine against rotenone-induced mitochondrial stress was 
abolished in both dct-1- and pink-1-deficient C. elegans. Tomatidine treatment also protected wild type C. elegans, 
www.nature.com/scientificreports/
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Figure 3. Tomatidine modulates mitochondrial homeostasis by stimulating both mitochondrial 
biogenesis and mitophagy. (A) Assessment of mitochondrial content in nematode pharynx determined by 
quantifying mitoTracker Red fluorescence (n = 15). Representative images are also shown. (B,C) Monitoring of 
mitochondrial network of the pharynx muscle cells in vehicle- and tomatidine-treated myo-3::GFP nematodes. 
Representative images are shown in panel B, and quantification of mitochondrial network scoring is shown in 
panel C (n = 40). (D) Immunoblot showing relative levels of the indicated mitochondrial proteins in control 
and tomatidine-treated human neural cells. For full-length gels see Figure S4A. (E) Detection of muscle cell 
mitophagy in vehicle- and tomatidine-treated nematodes. The mitophagy-screening strain N2;Ex(pmyo-
3::dsred::lgg-1;pdct-1::dct-1::gfp) was used for mitophagy detection. A set of representative images is shown. 
(F,G) Assessment of mitophagy in vehicle- and tomatidine-treated primary rat cortical neurons. Colocalization 
between the mitophagy dye and the lysosome dye were quantified (F) with a representative set images shown in 
panel G. (H,I) Assessment of mitophagy in vehicle- and tomatidine-treated human neural cells. Colocalization 
between the mitophagy dye and the lysosome dye were quantified (H) and representative images are shown in 
panel I. (J,K) Evaluation of mitophagy in vehicle- and tomatidine-treated HeLa cells expressing mt-mKeima 
(see Supplementary Methods for details). Ratios indicating relative levels of mitophagy were quantified (J) and 
representative images are shown in panel K. (L) Evaluation of C. elegans basal OCR was performed using a 
Seahorse XF96 instrument (mean ± S.E.M with n = 10 replicates/group). See also Figure S2.
www.nature.com/scientificreports/
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but not dct-1- and pink-1-deficient ones, against heat stress (Fig. 4C). These findings indicate that PINK-1/DCT-
1-related mitophagy contributes to the health-promoting and stress resistance effects of tomatidine.
Tomatidine induces mitophagy by activating the SKN-1/Nrf2 pathway. To elucidate the signaling 
pathway(s) by which tomatidine stimulates mitophagy, we used fluorescent reporter techniques and human HEK-
293 cells to determine whether tomatidine affected the promoter activity of several transcriptional activators that 
regulate mitochondrial homeostasis. These include the longevity and autophagy-regulating protein SIRT1, the 
master regulator of mitochondrial biogenesis PGC-1α , and the anti-oxidant nuclear factor E2-related factor 2 
(Nrf2)/antioxidant response element (ARE) pathway 8,26,43. While tomatidine did not affect SIRT1 or PGC-1α 
promotor activities (Figure S3A,B), tomatidine induced a significant increase of Nrf2/ARE reporter activity in a 
concentration-dependent manner (Fig. 5A).
Because tomatidine increased Nrf2/ARE reporter activity, we performed immunoblot analysis to measure 
levels of several proteins encoded by Nrf2-responsive genes in human neural cells exposed to tomatidine. Upon 
activation by ROS, Nrf2 translocates from the cytoplasm to the nucleus where it binds to the ARE region to 
transcriptionally activate genes which encode antioxidant proteins, including NAD(P)H quinone oxidoreductase 
1 (NQO1) and heme oxygenase 1 (HO1)43–45. Human neural cells exposed to tomatidine exhibited increased 
amounts of nuclear Nrf2, and increased levels of NQO-1 and HO-1 (Fig. 5B), indicating that tomatidine activates 
the Nrf2-ARE pathway. In control cells with normal levels of Nrf2, tomatidine induced a 20% increase in levels of 
ROS (Fig. 5C). Basal levels of ROS were increased in Nrf2-deficient cells, and tomatidine caused a large increase 
in ROS levels in the Nrf2-deficient cells (Fig. 5C). Moreover, tomatidine-induced mitophagy was attenuated in 
human neural cells in which Nrf2 was knocked down, and in cells treated with the antioxidant N-acetylcysteine 
(Fig. 5D), indicating that tomatidine stimulates mitophagy by a mechanism involving ROS-dependent activation 
of Nrf2. Collectively, these data suggest that tomatidine can induce activation of the Nrf2/ARE pathway, contrib-
uting to mitophagy induction.
To investigate whether activation of the Nrf2/ARE pathway in mammalian cells is also conserved at the organ-
ismal level, we examined the effect of tomatidine on the null C. elegans skn-1 (zu135) mutant strain (the C. ele-
gans skn-1 gene is orthologous to the mammalian Nrf2 gene). When pharyngeal pumping was assessed, 25 μ M 
tomatidine consistently enhanced pumping rate in adult wild type C. elegans (Fig. 5E). However, skn-1 mutation 
compromised tomatidine-induced increase of pumping rate, indicating that tomatidine requires Skn-1 activity 
Figure 4. Mitophagy is necessary for tomatidine-induced stress resistance in worms. (A) dct-1 knockout 
nematodes were treated with 25 μ M of tomatidine and pharyngeal pumping was assessed at day 5 and day 9 
(mean ± S.E.M., n = 39–40). (B) Day 4 nematodes treated with or without tomatidine were exposed to the 
mitochondrial toxin rotenone (25 μ M) for 2 days and survival was quantified on day 6 (mean ± S.E.M, n =  
41–61). (C) Day 4 nematodes treated with or without tomatidine were exposed to heat stress (37 °C for 7 h), and 
survival was quantified (mean ± S.E.M, n = 41–61).
www.nature.com/scientificreports/
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to enhance muscular function. It is possible that tomatidine may activate other stress response pathways key to 
mitochondrial stress, such as the mitochondrial unfolded protein response (UPRmt). Knocking down atfs-1, a key 
gene in regulating UPRmt expression46, compromised tomatidine-induced increase of pumping rate (Fig. 5F). This 
suggests that UPRmt may play a positive role in tomatidine-induced health benefits. Taken together, these data 
Figure 5. Tomatidine-induced mitophagy is mediated by ROS and activation of Nrf2/SKN-1. (A) Assessment 
of tomatidine-induced Nrf2/ARE activity in ARE-bla HEK-293 cells (mean ± S.E.M., n = 6). (B) Immunoblot 
showing effects of tomatidine on levels of the indicated proteins in human neural cells. Cells were treated with 
the indicated concentrations of tomatidine for 24 h. For Nrf2, the nuclear fraction was isolated and used for 
immunoblotting. For full-length gels see Figure S4B. (C) Changes of cellular ROS in WT and Nrf2 knockdown 
human neural cells treated with or without 4 μ M tomatidine. Cells were stained with DHE (an indicator of 
superoxide levels) followed by FACS analysis (mean ± S.E.M, n = 6). (D) Assessment of mitophagy in WT and 
Nrf2 knockdown human neural cells treated with or without 4 μ M tomatidine (24 h) or a ROS scavenger NAC 
(1 mM for 3 h) (mean ± S.E.M, n = 6). (E) Effects of tomatidine on pharyngeal pumping rate in N2 wild type and 
skn-1 (zu135) C. elegans (mean ± S.E.M, n = 30). See also Figure S3. (F) Pharyngeal pumping rate in both N2 wild 
type and atfs-1 RNAi knockout C. elegans (mean ± S.E.M, n = 20).
www.nature.com/scientificreports/
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indicate that tomatidine induces mitophagy and preserves cell function during aging, possibly through multiple 
stress response pathways, such as the Nrf2/Skn-1 pathway and the activation of UPRmt.
Discussion
Compromised mitochondrial quality and function contributes to biological and pathological aging, and many 
major aging-related diseases. Accumulation of damaged mitochondria within cells can trigger apoptosis, inflam-
mation, and cell senescence4,6,47. Sarcopenia is a common aging phenotype for which there is no effective therapy, 
affecting 13–24% of people over 60 years old and increasing to more than 50% in people over 80 years old30,48. 
With a growing older population, there is great interest in developing pharmacological approaches to inhibit 
the progress of sarcopenia and other aging pathologies, thereby promoting healthier aging. Recent studies sug-
gest that pharmacologically improving mitochondrial quality may alleviate muscle atrophy in aged mice49–51. 
We found that tomatidine preserves muscle function during aging, and extends lifespan, in C. elegans. Further 
studies are necessary to dissect the specificity of the beneficial effects of tomatidine in C. elegans. For example, it 
is conceivable that the bacteria upon which the worms feed could metabolize tomatidine to a different compound 
that, in turn, exerts a beneficial effect on the worms. However, it is important to note that tomatidine improves 
mitophagy in both C. elegans and cultured human cells that lack bacteria. Additionally, it would be interesting 
to investigate whether other steroids with a similar structure to tomatidine produce similar effects in C. elegans.
Our findings suggest that tomatidine may protect C. elegans muscle function from age-related deterioration 
by activating the Nrf2/SKN-1-DCT-1 pathway and up-regulating mitophagy and antioxidant cellular defenses. 
A recent study in mice provided evidence that tomatidine stimulates the growth of mouse skeletal muscle cells, 
in part by activating the mTOR pathway30. In humans, sarcopenia is a common feature of aging that involves the 
accumulation of dysfunctional mitochondria and associated deterioration of muscle fiber cells themselves, in 
combination with infiltration of adipocytes and inflammatory immune cells52. In addition, an impaired ability 
of muscle stem cells to generate new myocytes may be impaired with aging and more so in sarcopenia53. All cells 
that comprise C. elegans pharyngeal muscles are postmitotic muscle cells. The beneficial effects of tomatidine in 
counteracting age-related deterioration of muscle function in C. elegans are therefore not the result of effects on 
muscle stem cells or immune cells. Instead, our findings suggest that tomatidine may influence either the muscle 
cells themselves, or the nervous system associated with muscle function, and therefore may be particularly rele-
vant to processes occurring within skeletal muscle fiber cells in sarcopenia.
Emerging evidence suggests a pivotal role of mitophagy in health and aging4,5,51, pointing to the possibility that 
mitophagy induction can improve healthspan and lifespan. We show here, for the first time, that a natural product 
can not only induce mitochondrial biogenesis, but also enhance the quality of the cellular mitochondrial pool 
by stimulating mitophagy. The mitophagy induction by tomatidine was stringently evaluated by several mito-
phagy detection methods targeting the mitophagosome or mitolysosome (Fig. 3). Most importantly, mitophagy 
is required for tomatidine-induced extension of healthspan and stress resistance. Since we did not detect changes 
of reporter activities of SIRT1 and PGC-1α in cells exposed to tomatidine, our data suggest that the mitochon-
drial benefit of tomatidine is dependent on the Nrf2/SKN-1 pathway. However, we do not rule out the possibility 
that tomatidine may, directly or indirectly, change SIRT1 or PGC-1α activities at post-translational levels, for 
example by changes in deacetylation activity. Also, this does not rule out other mechanistic pathways that could 
play a role in tomatidine-dependent improvement of mitophagy. For example, tomatidine may upregulate mito-
phagy through induction of p62 via the Nrf2/SKN-1 pathway. p62 (also named sequestosome 1/SQSTM1) is a 
major autophagy receptor that involves in the maturation of autophagosome and the autophagic degradation of 
polyubiquitin-containing bodies54. Recently, it has been shown that a synthetic p62-mediated mitophagy inducer 
(PMI) can activate mitophagy through upregulation of p62 via the ARE-Nrf-2 pathways55,56. Thus, future work on 
the effect of tomatidine on p62 is of interest. In all, our findings suggest that tomatidine stimulates mitophagy by 
activation of the PINK1/DCT-1 pathway via Nrf2/SKN-1 activation, which is an important pathway for enhanc-
ing mitochondrial and muscle health in young and old worms.
Although cellular stress response signaling and mitophagy have both been proposed to be essential in health 
maintenance, an interplay between Nrf2 and mitophagy in aging has not been established. A recent study found 
repression of the Nrf2 pathway in a premature aging disease, Hutchinson-Gilford progeria syndrome (HGPS). 
HGPS is caused by mutation of the nuclear architectural proteins lamin A and C, with HGPS patients showing 
profound growth delays and premature aging phenotypes, including cardiac muscle and skeletal muscle pathol-
ogies57,58. Compromised Nrf2 activity contributes to premature aging in experimental models of HGPS through 
increasing chronic oxidative stress, and reestablishment of the Nrf2 pathway using small compound Nrf2 activa-
tors ameliorates disease phenotypes58. We showed that tomatidine triggers mitophagy and induces Nrf2 activa-
tion, and deficiency of either mitophagy or Nrf2/SKN-1 compromises stress resistance and impairs mitochondrial 
function. Furthermore, we showed a causative relationship between Nrf2 activation and mitophagy induction. 
In addition, accumulating evidence suggests a signaling role for ROS in the stimulation of mitophagy in cells 
under mild stress. Studies from yeast and mammalian cells suggest moderately elevated ROS levels can induce 
mitophagy, which then clears aged or dysfunctional mitochondria. However, if mitophagy is compromised and/
or ROS levels are excessively high, mitochondrial dysfunction becomes exacerbated in a vicious cycle59,60. Thus, 
growing evidence from both laboratory and clinical studies shows that ROS has a dynamic role in health and 
disease. While excessive ROS can cause cellular and systemic damage and promote disease, moderately elevated 
ROS levels enhance cellular stress resistance and protect against disease17,21. In line with these findings, we show 
that tomatidine can induce a moderate increase in ROS levels which is necessary to trigger mitophagy.
Many of the chemicals produced in vegetables, fruits and other plants (phytochemicals) that have been found 
to have beneficial effects on cells and organisms are believed to function as noxious agents (i.e., ‘antifeedants’ or 
toxins) that dissuade insects and other organisms from consuming the plants22. Herbivorous organisms evolved 
multiple mechanisms to prevent consumption of toxic amounts of the phytochemicals including taste receptors, 
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emesis, enzymes (cytochrome p450s) that rapidly metabolize the phytochemicals, and adaptive stress response 
pathways in cells throughout the body and brain. Phytochemicals that activate adaptive cellular stress response 
pathways typically have a bitter taste22. Examples of phytochemicals that activate the Nrf2 antioxidant response 
pathway include sulforaphane, curcumin, and plumbagin23. Such noxious phytochemicals are typically concen-
trated in the parts of plants that are exposed to the environment and/or are involved in seed production including 
the ‘skin’ of fruits, and developing buds/sprouts. In the case of the tomato fruit, tomatidine is present in high 
amounts in the unripe green tomato and in much lower amounts in the ripe red tomato. This is consistent with a 
role for tomatidine in protecting the unripe tomato against consumption, with the reduction in tomatidine levels 
in the ripe fruit then enabling consumption of the fruit and dispersal of the seeds by the consumer61. Our findings 
suggest that moderate amounts of tomatidine can activate adaptive cellular stress responses in muscle cells or 
neurons that protect cells against metabolic and oxidative stress, which can counteract age-related dysfunction 
and degeneration. One prominent response of cells to tomatidine is induction of mitophagy, which preserves 
cellular function during aging. Because mitochondrial dysfunction and defective mitophagy are implicated in the 
etiology of several major age-related diseases, including sarcopenia, diabetes, Alzheimer’s disease and Parkinson’s 
disease, it will be of considerable interest to determine whether tomatidine has beneficial effects in animal models 
of these disorders.
Materials and Methods
C. elegans strains and cultivation. C. elegans were grown on standard nematode growth medium (NGM) 
and maintained following standard protocols as described previously62. The Bristol strain N2 (wild type), CB5600 
ccIs4251[pSAK2 (myo-3p::gfp-lacz(NLS)) + psak4 (myo-3p::mitochondrial gfp)I, and skn-1(zu135) were obtained 
from the Caenorhabditis Genetics Center (CGC). The mitophagy reporter strain N2;Ex(pmyo-3::dsred::lgg-1; 
pmyo-2GFP )Ex(pdct-1::dct-1::gfp; pRF4) was from Prof. N. Tavernarakis (University of Crete, Greece)5. All C elegans 
were cultured at 25 °C on solid NGM agar plates with OP50 food source unless otherwise noted62.
C. elegans longevity assays. Lifespan analysis was performed as mentioned previously8,37,38. About 8–10 
adult D1 C. elegans were transferred to 4 plates and allowed to lay eggs for 5 hours to give rise to synchronous pop-
ulation. After hatching, L4 stage nematodes were transferred to respective condition plate with either 10, 25, or 
50 μ M of tomatidine (all with 50 μ M FuDR). Animals were scored as dead or alive every other day. Missing worms 
were censored from the lifespan count. Significance was determined by log rank test, and mean was calculated 
by averaging the days of C. elegans death for each condition. Figures display a smoothed Kaplan Meier survival 
curve of the pooled populations.
Luciferase assays of promoter activities for Nrf2/ARE, SIRT1 and PGC-1α. Luciferase assays 
were performed as described elsewhere26,43. The ARE-bla construct was used for Nrf2/ARE reporter assay43; the 
PGC-1α -2kb (the Renilla luciferase-expressing plasmid/pRL-TK used as an internal control.) was for PGC-1α 
promoter activity detection26.
SIRT1 promoter activity was detected by a pTA-Luc SIRT1 promoter (-202), a gift from Dr. Toren Finkel63. In 
Brief, plasmids were transfected to HEK-293 cells for 24 h, cells were then treated with different concentrations of 
tomatidine for 24 h. Luciferase activity was measured using a Dual-Luciferease-Reporter System (Promega), and 
luciferase activity for each well as normalized to the internal renilla luciferase activity.
Quantification of swimming, maximum velocity, and pharyngeal pumping. These methods are 
detailed elsewhere64,65. Briefly, for swimming movement, nematodes from a treatment group were randomly 
selected and transferred to a 6 cm petri dish containing 1 mL of M9 buffer. They were allowed to acclimate for 
~10 s, then movements were scored for 30 seconds. Maximum velocity was determined as described previously33. 
N2 worms were exposed to designated concentrations of tomatidine (0, 10, 25, and 50 μ M) beginning at L4 stage 
and maximum velocity of movement was determined on designated days. In brief, worms for imaging were 
moved to physical assay plate void of bacterial lawn. The recording system was a stereomicroscope (Unitron 
2850), a charge-coupled device camera (Infinity 2, Lumenera), and imaging software. Four to eight nematodes 
were placed in one plate and recorded for 30 s, followed by data analysis using ImageJ and wrMTrck Batch (www.
phage.dk/plugins).
For measurements of pharyngeal pumping (contractions) C. elegans were synchronized and raised to adults as 
mentioned in the longevity assay methodology. At designated ages pharynx contractions were manually counted 
for 30 s. Experiments were blinded and two or more researchers quantified pumping and swimming to decrease 
bias. Significance was calculated by student t-test.
Age stage scoring of pharyngeal morphology. We imaged anesthetized worms, immobilized between 
an agarose pad and a number 1 coverslip, with an NA 1.4, 60x objective on an inverted Nikon Eclipse E800 
microscope. The CCD output was saved as a stack and opened with ImageJ, for animals of a given cohort (drug 
treatment, age, etc.). A custom script was used to center a region of interest around the terminal bulb of each 
individual animal; the 300 × 300 pixel ROI was saved as a TIFF files, named systematically and later used to score 
the worms apparent age, as described35.
C. elegans basal respiration. Basal oxygen consumption was measured per previous methods66 using a 
Seahorse XF96 instrument (Seahorse Bioscience Inc.). In brief, around 200 L4 nematodes/group were transferred 
to designated drug plates, followed by OCR detection on adult days 1 or 4. On the day of the experiment, all the 
C. elegans were collected using M9 buffer washing, followed by washing with M9 buffer twice. Nematodes were 
then re-suspended and transferred in 96-well standard Seahorse plates (#100777–004) (10~15 worms per well), 
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and basal OCR was measured six times. After the experiments, nematodes numbers were counted, followed by 
data normalization to the number of nematodes in each individual well. We had ten replicates for each group, and 
repeated the experiment twice.
Worm muscle mitochondrial network scoring. We used a myo-3::gfp reporter strain for mitochondrial 
networking morphology analysis in the body wall muscles. Worms were treated with the designated drugs from 
L4 stage for 4 days followed by imaging with a Zeiss confocal microscopy. We imaged over 15 worms/group each 
time (repeated two to three times). Mitochondrial network was evaluated in a double-blinded manner. A scoring 
scale of 1 to 5 was used, where a score of 5 denotes a perfectly organized mitochondrial network with healthy 
mitochondria running parallel with the myofilament lattice. For highly fragmented and disorganized mitochon-
drial network morphology, a score of 1 was given.
RNA interference in C. elegans. RNA interference (RNAi) was performed as we did previously67. RNAi 
feeding constructs for L4440 (control), dct-1, pink-1, and atfs-1 were derived from two RNAi feeding libraries 
(Dr. Sige Zou’s laboratory (previously form NIA) and the other one from Open Biosystems [the E. coli host strain 
is HT115 (DE3) (Fire Lab)]). RNAi was performed with worms maintained on the RNAi from egg laying stage 
throughout the experiment67.
Metabolomics for C. elegans tissues. Whole worm tissue metabolomics were assessed with a method 
as described previously67. To evaluate changes of metabolome in N2 (veh) and N2 (tomatidine) worms, whole 
body tissues of adult Day 7 worms were collected and subjected to ALEX-CIS GCTOF mass spectrometry, UC 
Davis Genome Center Core Facilities. Four replicates were prepared for each group. Data were then normalized 
to internal control, followed by heat-map and TCR cycle analysis.
Stress assays. Stress assays were conducted as described previously5. Briefly, C. elegans were treated with 
different doses of tomatidine, followed by exogenous stress exposure including either 25 μ M rotenone for two 
days or exposure to 37 °C for 7 h. Nematodes were then evaluated for survival. Significance was calculated by 
student t-test.
RNA isolation and Microarray. N2 C. elegans from L4 stage were exposed to either vehicle (1% DMSO) 
or 25 μ M tomatidine (Sigma-Aldrich, USA). On adult day 7, nematodes where collected by washing off the plates 
with M9 buffer from four independent experiments. Samples were stored at − 80 °C in lysis reagent (Qiagen Cat. 
no. 75142). Crude extracts were prepared by bead beating packed nematode pellets with the Mini-Beadbeater 8 
(Biospec Products, Oklahoma), and total RNA isolated using RNeasy Mini Kit on the QIAcube per the manufac-
turer’s protocol (Qiagen, California). RNA concentration and quality was measured by Nanodrop (ThermoFisher, 
Waltham, MA USA) and the Agilent Bioanalyzer RNA 6000 Chip (Agilent, Santa Clara, CA). Two-hundred ng 
total RNA was labeled using the Agilent Low-Input QuickAmp Labeling Kit, and purified and quantified per 
the manufacturer’s instructions. A total of 825 ng Cy3-labeled cRNA was hybridized for 17 hours to Agilent 
C. elegans 4 × 44 K oligo microarrays. Following posthybridization rinses, arrays were scanned using an Agilent 
SureScan microarray Scanner at 3 micron resolution, and hybridization intensity data extracted from the scanned 
images using Agilent’s Feature Extraction Software. Raw microarray hybridization intensity data from four sep-
arate experiments were log-transformed. Three separate probe preparations were used individually or combined 
in equal amounts for the fourth hybridization. Raw microarray data were log transformed to yield z-scores. The 
z-ratio was calculated as the difference between the observed gene z-scores for the experimental and the control 
comparisons, and dividing by the standard deviation associated with the distribution of these differences. Z-ratio 
values of ± 1.5 were used as cut-off values and calculated using a 5% false discovery rate (FDR) threshold. The 
complete set was tested for gene set enrichment using parametric analysis of gene set enrichment. For each path-
way z-score, a p-value was computed using JMP 6.0 software to test for the statistical significance.
Detection of mitophagy in cells and C. elegans. Mitophagy in nematodes was measured using a mito-
phagy reporter strain N2;Ex(pmyo-3::dsred::lgg-1;pdct-1::dct-1::gfp). Nematodes were exposed to tomatidine at 
L4 stage, followed by imaging of muscle cells at adult D4. A total of 15~20 nematodes/group were imaged in three 
independent replicates. Colocalization coefficient between DSRED::DCT1 and LGG1::GFP were analyzed using 
the Zeiss LSM Image Examiner.
For mitophagy evaluation in cultured cells, we used different cell systems, including primary rat cortical neu-
rons, human SH-SY5Y neural cells, and the mt-mKeima HeLa cells. A commercial mitophagy kit was used for 
mitophagy detection in both neurons and SH-SY5Y cells (Dojindo Laboratories). Imaging of mt-mKeima cells 
(gift from Dr. Richard Youle) was performed as reported by Nuo and colleagues41, using different settings for GFP 
(alkaline condition, excitation 458 nm and emission 615 nm) and RFP (acidic condition, excitation 561 nm and 
emission 615 nm).
Statistics. For the worm lifespan analysis, the log rank test was used for statistical analysis. For two group 
comparison, two tailed student t-test was applied. GraphPad Prism 5 (GraphPad Software, Inc.) was used for 
statistical analyses. The p values < 0.05 were considered statistically significant.
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